{"organizations": [], "uuid": "ca323f4ecb2638faf8a60787a465e1f4869f04e1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-strongbridge-biopharma-announces-p/brief-strongbridge-biopharma-announces-pricing-of-public-offering-idUSASB0C2IY", "country": "US", "domain_rank": 408, "title": "BRIEF-Strongbridge Biopharma Announces Pricing Of Public Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-26T02:41:00.000+02:00", "replies_count": 0, "uuid": "ca323f4ecb2638faf8a60787a465e1f4869f04e1"}, "author": "", "url": "https://www.reuters.com/article/brief-strongbridge-biopharma-announces-p/brief-strongbridge-biopharma-announces-pricing-of-public-offering-idUSASB0C2IY", "ord_in_thread": 0, "title": "BRIEF-Strongbridge Biopharma Announces Pricing Of Public Offering", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-strongbridge biopharma announces pricing of public offering", "sentiment": "negative"}, {"name": "brief-strongbridge biopharma announces pricing of public offering reuters sta", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "strongbridge biopharma plc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - Strongbridge Biopharma Plc:\n* STRONGBRIDGE BIOPHARMA PLC ANNOUNCES PRICING OF PUBLIC OFFERING OF ORDINARY SHARES\n* STRONGBRIDGE BIOPHARMA PLC SAYS PRICED ITS UNDERWRITTEN PUBLIC OFFERING OF 5 MILLION ORDINARY SHARES AT A PRICE TO PUBLIC OF $6.75 PER SHARE Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-01-26T02:41:00.000+02:00", "crawled": "2018-01-26T02:56:47.018+02:00", "highlightTitle": ""}